Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction
No reflow defined as an altered myocardial reperfusion and failure at microvascular level is a frequent complication in acute myocardial infarction that attenuates beneficial effect of reperfusion therapy leading to poor outcomes. There is not enough evidence to support that previous use of statins improves coronary flow in patients undergoing primary percutaneous coronary intervention (PCI).
Source: Archives of Medical Research - Category: Research Authors: Rosalba C. Garc ía-Méndez, Eduardo Almeida-Gutierrez, Leonor Serrano-Cuevas, Jesús Salvador Sánchez-Díaz, Martín Rosas-Peralta, Jose Alberto Ortega-Ramirez, Jose Antonio Palomo-Villada, Irma Isordia-Salas, Rosa Marisol Alonso-Bravo, Gabriela Borrayo Tags: Preliminary Report Source Type: research
More News: Angioplasty | Atorvastatin Calcium | Cholesterol | Coronary Angioplasty | Heart Attack | Lipitor | Percutaneous Coronary Intervention | Research | Statin Therapy | Zivast